Login
From:
Myasthenia Gravis News
(Uncensored)
subscribe
Telitacicept reduces gMG severity in Phase 2 study
https://myastheniagravisnews.com/news/telitacicept-reduces-gmg-severity-phase-2-study/
links
backlinks
Tagged with:
clinical trial
telitacicept
Treatment with telitacicept for almost six months lessened disease activity in gMG adults positive for anti-AChR antibodies, per a study.
Roast topics
Find topics
Find it!
